TDC
55
-2
CL
72
3
HPE
51
-2
ADT
15
-5
GME
60
-7
CMG
66
2
BF.B
53
3
CA
40
-4
HD
50
10
WU
18
2
MMM
25
-3
HAL
29
3
FAST
45
3
UNM
56
4
SE
58
11
NWSA
71
-4
PYPL
31
-2
KMX
58
4
WM
80
4
PAYX
54
6
TDC
55
-2
CL
72
3
HPE
51
-2
ADT
15
-5
GME
60
-7
CMG
66
2
BF.B
53
3
CA
40
-4
HD
50
10
WU
18
2
MMM
25
-3
HAL
29
3
FAST
45
3
UNM
56
4
SE
58
11
NWSA
71
-4
PYPL
31
-2
KMX
58
4
WM
80
4
PAYX
54
6
Financhill
Back

Anterix Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
28

ATEX
Anterix

Last Price:
30.46
Seasonality Move:
-4%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.04
Seasonality Move:
3.65%
Sell
28
Anterix (ATEX) is a Sell

Is Anterix a Buy, Sell or Hold?

  • The current Anterix [ATEX] share price is $30.77. The Score for ATEX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ATEX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATEX Stock Price Chart

What is Anterix's stock price today?

  • The Anterix share price today is $30.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATEX is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

ATEX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 30.6 Sell
Chaikin Money Flow: -203057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.86 - 33.4) Sell
Bollinger Bands (100): (30.91 - 35.79) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

ATEX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.83 Sell
20-day SMA: 32.61 Sell
50-day SMA: 32.34 Sell
200-day SMA: 32.73 Sell
8-day EMA: 31.71 Sell
20-day EMA: 32.25 Sell
50-day EMA: 32.6 Sell
200-day EMA: 32.96 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Anterix Earnings Growth & ATEX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.05 per share, and a decrease next year of $1.58 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Anterix Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):